DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study
Conclusion: DV may be a useful biomarker for early prediction of therapeutic outcome in intermediate HCC. Published on 2018-04-20 13:58:11
Source: Journal of the Belgian Society of Radiology - Category: Radiology Source Type: research
More News: Belgium Health | Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Radiology | Study | Urology & Nephrology